Caption Management, LLC Ptc Therapeutics, Inc. Transaction History

Caption Management, LLC

$6.13 Billion
Q2 2024

A detailed history of Caption Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 30,000 shares of PTCT stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,000

Previous 30,000 -0.0%

Holding current value

$1.13 Million

Previous $872,000 5.16%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $155,547 - $252,755	6,300 New	6,300 $192,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $506,443 - $948,932	-22,599 Reduced 91.43%	2,119 $47,000
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $998,607 - $1.46 Million	24,718 New	24,718 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $121,267 - $214,254	4,737 Added 1801.14%	5,000 $200,000
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $893,310 - $1.08 Million	-24,137 Reduced 98.92%	263 $10,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $2.59 Million - $3.34 Million	-60,762 Reduced 71.35%	24,400 $1.24 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $771,636 - $1.42 Million	-23,838 Reduced 21.87%	85,162 $3.8 Million
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $2.22 Million - $3.45 Million	69,000 Added 172.5%	109,000 $5.24 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $845,500 - $1.2 Million	25,000 Added 166.67%	40,000 $1.35 Million
Q4 2018 Jan 30, 2019	SELL	$29.83 - $46.51 $223,725 - $348,825	-7,500 Reduced 33.33%	15,000 $514,000
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $578,250 - $1.08 Million	22,500 New	22,500 $759,000

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Ptc Therapeutics, Inc. Transaction History